IMAX CORP (IMAX)
CA45245E1097 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to IMAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.5. This target is 28.99% above the current price.
IMAX was analyzed by 16 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IMAX.
In the previous month the buy percentage consensus was at a similar level.
IMAX was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-22 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-16 | Benchmark | Reiterate | Buy -> Buy |
| 2024-04-10 | Benchmark | Reiterate | Buy -> Buy |
| 2024-04-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2024-03-04 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-13 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-02-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-01-18 | Benchmark | Maintains | Buy -> Buy |
| 2024-01-11 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-01-02 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-12-05 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-10-10 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-10-09 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-25 | Rosenblatt | Maintains | Buy -> Buy |
| 2023-08-18 | Rosenblatt | Maintains | Buy -> Buy |
| 2023-07-28 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-07-27 | Rosenblatt | Maintains | Buy -> Buy |
| 2023-07-27 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-07-20 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-07-13 | Benchmark | Reiterate | Buy -> Buy |
| 2023-07-13 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-07-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-07-12 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-05-02 | Barrington Research | Reiterate | Outperform |
| 2023-05-02 | Benchmark | Maintains | Buy |